MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ccd.27159

Медицинская библиотека · Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2017

Left ventricular ejection fraction of < 20%: Too bad for MitraClip© ?

Barth Sebastian, Hautmann Martina B, Kerber Sebastian, Gietzen Frank, Reents Wilko, Zacher Michael, Halbfass Philipp, Griese Daniel P, Schieffer Bernhard, Hamm Karsten

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVES

This study sought to investigate whether the percutaneous mitral regurgitation (MR) reduction with the MitraClip® system in end-stage heart failure patients with a left ventricular ejection fraction (LVEF) of <20% also effects beneficial outcome or whether the underlying myogenic problem is leading and therefore of prognostic relevance.

BACKROUND: The interventional treatment of functional mitral regurgitation (FMR) with the MitraClip® system could improve the clinical and hemodynamic outcome in patients with severely impaired left ventricular function.

MATERIALS AND

METHODS

Between 2011 and 2016, a total of 147 patients with FMR were treated with MitraClip® at our institution. The cohort was divided into two groups: LVEF ≥ 20% (N = 126) and <20% (N = 21). Follow-up assessments included exercise capacity, 6-min walk test, probrain natriuretic peptide-measurement (ProBNP), echocardiography and right heart catheterization. Only three patients with an LVEF ≥ 20% and one patient with an LVEF < 20% were lost for follow-up.

RESULTS

In the vast majority of patients, a reduction from severe to mild MR was demonstrated with no difference between both groups (P = 0.422). At follow-up, both subgroups experienced similar improvements in exercise capacity and hemodynamics. Patients with an LVEF < 20% were on average 5.8 years younger, while mortality rates were comparable in both groups (P = 0.760).

CONCLUSION

By careful selection, even patients in the end stage of advanced LV dysfunction as the result of the underlying myogenic problem and the additional harmful effects of the high volume loading due to the FMR can exhibit significant clinical and hemodynamic improvement after MitraClip© therapy.

Для цитирования: Barth Sebastian, Hautmann Martina B, Kerber Sebastian, Gietzen Frank, Reents Wilko, Zacher Michael, Halbfass Philipp, Griese Daniel P, Schieffer Bernhard, Hamm Karsten. Left ventricular ejection fraction of < 20%: Too bad for MitraClip© ?. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2017. DOI: 10.1002/ccd.27159.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.